Germany's Bayer has continued the revamp of its business units by
setting up its chemicals, technology services and healthcare
activities as three separate legal entities. The move follows the
carve-out of Bayer CropScience a...
Mary Harney, the Irish Deputy Prime Minister and incoming President
of the European Union's Competitiveness Council will speak at the
opening plenary session of the CORDIA - EuropaBio Convention 2003,
on 2 December in Vienna,...
Swedish company Perbio Science has agreed to a $714 million (€626m)
takeover by Fisher Scientific International of the USA, which says
that it sees the acquisition as a means of capitalising on the
strong growth of the life science...
Contract research organisation (CRO) revenues have been growing
strongly as a result of drug developers' need to reduce R&D
costs while shortening product evaluation times. However, as demand
for more efficient preclinical...
Profile Therapeutics has reported strong growth in sales and a
reduced operating loss for the year-ended June 30, and expects this
trend to continue as its R&D efforts in improved nebuliser
technologies come to fruition.
Recordati is expecting to sell off its pharmaceutical chemical
operations by the end of next year or early in 2004, according to
the company's chief executive, who expects €80-€90m in proceeds for
Companies that supply instruments and consumables to the life
sciences industry have been hit hard by reined in research spending
resulting from the current adverse economic climate. However, one
chief executive believes there are...
The creditors of Australian over-the-counter medicines and vitamins
manufacturer Pan Pharmaceuticals have rejected a rescue bid for the
company at a meeting held last week. Another meeting is due to be
held later today.
Chiron's headquarters is hit by two homemade bombs, with an animal
rights group claiming responsibility. The blasts caused no
casualties and only minor damage to property, but represent an
alarming escalation in the tactics used...
French company Flamel Technologies has added another high-profile
client for its drug delivery technology spurring another leap in
its shares that have already climbed almost 800 per cent over the
last 12 months.
Australian packaging group Amcor has entered into a A$330 million
(€198m) agreement to buy Rexam's healthcare flexibles packaging
business and will also buy out Danisco and Ahlstrom's 28.1 per cent
minority stake in its...
US e-business software company Fugensoft has revamped its product
range, introducing a suite of new products and a change of focus,
to meet the needs of the biotech and pharmaceutical industry 'where
there is a huge need for...
Top pharmaceutical manufacturing plants strive to achieve efficient
operations that result in increased profitability as well as
superior product quality and satisfied customers. These are the
findings of a new study from market research...
A new report from Datamonitor predicts the end of the
pharmaceutical industry's blockbuster product model, pointing to a
dramatic shortfall in growth rates for billion dollar-plus products
out to 2008.